Hind sight is always 20/20 and you never know. I can't tell you how many times I bought a stock for all the right reasons, sold a large bump up looking to buy it back lower and that never happened... With Arena it is not worth the risks, buy and hold for retirement.
Why do you always need to make it nasty and personal? Are angry because you can't change everyone's opinion to yours? Traders are the only ones that care about charts. Long term investors buy the science that the vision of the company 2,3, 5 years out. We make our investment and as long as the company executes and continues to move forward we Stay the Course. Only when things fundamentally change do we reevaluate the investment. Long term investors buy shares, they don't play options or margin, they don't try to over think things.
We lock our money away at a price we feel is a discount to where the company will be in the future based on our DD and opinion. That is what makes the market you can disagree with us. Fine do so, but not everyone trades or speculates like you do. Many on here started DCAing back at 1.50-1.90 so all that has happened is they have given up profit in the short run.
The 12-15, shorts do not want to be short after this. Doctors will get to hear the facts about Belviq and get to ask questions. More data to ease their concerns from Fen Phen past and the benefits of Belviq for pre diabetics. A lot of doctors will be attending this conference.
We already know what they are going to spend they told us. This is nothing new, we have a monster pipeline with more then one billion dollar blockbuster being being moved through the pipeline.
ARNA employees are just like you and I, they go to work to make money and pay their bills. Many of the Arena employees are buying stock through their ESOPs and other bonus options... IF they were money managers or traders they would not be working for Arena they would be on Wall Street.
We have over 200 million in the bank and about 40 million a year coming in going forward, what are you talking about?
I am sure they got some longs to sell at this point. I agree we have nothing in reality happening that warrants this kind of sell off the last few weeks. We are executing and that is the key. Scripts are growing, we are gaining market share, the market for people taking weight loss drugs is growing, studies are completed and data is getting analyzed. We are moving the pipeline forward and before the end of the year we should see the Bel PHen study data and the Belviq for smoking study data. Unofficial results are very positive. Insurance coverage is growing which should get more people reordering Belviq.
These sanctioned bear raids unfortunately are part of the markets these days. We just have to learn to live with them.
Nice find. Is this study parallel to our long term mace study for 5 years required by the FDA for this new and novel compound? Seems to have a little more going on in it. Unknown if this is the study needed to get EU approval moving forward, we pulled because of the non clinical study looking into the rat tumors....
Found not duration or time line for the study.
The market is fickle and short sighted and because of that lots of money can be made by the patient and those doing DD.
In the short run the stock market is a popularity vote, and right now and for the last year Arena is not liked by the powerful and not a very popular stock. But in the long run the stock market is a voting machine, where long term investments are made on the stocks that everyone is voting will win.. Look at the major investments by large institutional investment houses. That bodes well for the company.
Short interest indicates that a large number of folks still believe the stock is going to stumble for a while and probably are betting that a money raise will be needed. Getting great news on one of the pipeline drugs and getting a partner for that drug would go a long way in scaring off the remaining shorts. It is clear that it will be a while longer before Belviq will be able to fund the pipeline.
At some point our script numbers should get us away from comparing to Qsymia and others and it should be about Belviq becoming a market leader. We are outgrowing every other drug in the weight loss universe. We are taking market share or better yet we are building the market by growing the market...
This is the thing Wall Street and others are not going to talk about. It appears the market of patient taking weight loss drugs is growing and that growth is picking Belviq over the other drug options... In a very short time we will be looking at numbers over 20,000 a week from Symphony and over 15,000 from IMS. That is a huge step forward and will results in doubling our revenue...
But ARNA is not trading based on what it potentials are or what its revenue is going to look like in another 2 years. The stock price has disconnected from reality or the world of what will be.
They want to stop people like Carl Icahn from buying enough shares and getting a board seat quickly. This move is to slow activist or potential take over of management down.
She is posting facts and numbers on the script data that is not a criminal enterprise.
How was that compared to the overall market, we should have increased market share again by a lot.
Not sure why you feel scammed, the company is developing drugs and moving very hopeful drugs through the system. That is what they do. We come out with numbers that are officially higher then Qsymia ever went which prove we are not going to have a script curve like them and are now taking market share and the price gets hammered. Nothing Arena management can do about this.